(Q39884962)

15 September 2017

title

Ethnic-specific correlations of visfatin with circulating markers of endothelial inflammation and function (English)

1 reference

15 September 2017

0 references

0 references

2

0 references

Leoné Malan

5

0 references

Aletta E. Schutte

9

0 references

Hugo Huisman

object named as

Hugo W Huisman

3

0 references

author name string

Manja Reimann

1

1 reference

15 September 2017

Rudolph Schutte

4

1 reference

15 September 2017

Johannes M Van Rooyen

6

1 reference

15 September 2017

Rainer H Böger

7

1 reference

15 September 2017

Nicolaas T Malan

8

1 reference

15 September 2017

publication date

14 May 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

17

1 reference

15 September 2017

issue

12

1 reference

15 September 2017

page(s)

2210-2215

1 reference

Hypertension in sub-Saharan African populations

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Obesity in South Africa: the South African demographic and health survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Inflammation, obesity and cardiovascular function in African and Caucasian women from South Africa: the POWIRS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Leptin is independently associated with systolic blood pressure, pulse pressure and arterial compliance in hypertensive African women with increased adiposity: the POWIRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Serum levels of the adipokine visfatin are increased in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Fifteen years experience with finger arterial pressure monitoring: assessment of the technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Performance and utility of a cost-effective collagen-binding assay for the laboratory diagnosis of Von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Should obesity be blamed for the high prevalence rates of hypertension in black South African women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Visfatin is an adipokine, but it is not regulated by thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Increased visfatin concentrations in women with gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-kappaB pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Computation of aortic flow from pressure in humans using a nonlinear, three-element model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

The static elastic properties of 45 human thoracic and 20 abdominal aortas in vitro and the parameters of a new model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Elevated resistin is related to inflammation and residual renal function in haemodialysed patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

Obesity-associated hypertension: new insights into mechanisms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.157

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2009.157

1 reference

15 September 2017

1 reference